Shree Ganesh Biotech (India) share news, announcements and annual reports
BSE: 539470Pharmaceuticals & BiotechnologySmall Cap
Shree Ganesh Biotech (India) Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 2015
Last close ₹0.45up ₹0.02 (4.65%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹0.43.
2 Nov: open ₹0.44, high ₹0.45, low ₹0.43
52-week range of traded prices to 2 Nov 2026
₹0.40Low, 30 Oct 2026₹0.75High, 3 Nov 2025
- Next results date: the board meets on 2 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹18 Cr3,998th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.28
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,43,142
Shree Ganesh Biotech (India) board meetings
108 filed, newest first. Page 2 of 3.
May 2022
5 May · Board meeting
Meeting on 23 May 2022: audited results
Mar 2022
Feb 2022
3 Feb · Board meeting
Meeting on 7 Mar 2022: bonus issue
Jan 2022
25 Jan · Board meeting
Meeting on 1 Feb 2022: quarterly results
Dec 2021
10 Dec · Board meeting
Meeting on 20 Dec 2021: stock split
Nov 2021
Oct 2021
28 Oct · Board meeting
Meeting on 13 Nov 2021: quarterly results
Aug 2021
5 Aug · Board meeting
Meeting on 11 Aug 2021: quarterly results
Jun 2021
17 Jun · Board meeting
Meeting on 25 Jun 2021: audited results
Jan 2021
11 Jan · Board meeting
Meeting on 19 Jan 2021: quarterly results
Oct 2020
21 Oct · Board meeting
Meeting on 30 Oct 2020: quarterly results
Aug 2020
27 Aug · Board meeting
Meeting on 3 Sep 2020: quarterly results
Jun 2020
5 Jun · Board meeting
Meeting on 18 Jun 2020: audited results3 Jun · Board meeting
Meeting on 9 Jun 2020: audited results and quarterly resultsNot held on this date
Mar 2020
5 Mar · Board meeting
Meeting on 13 Mar 2020
Jan 2020
20 Jan · Board meeting
Meeting on 1 Feb 2020: quarterly results
Oct 2019
15 Oct · Board meeting
Meeting on 25 Oct 2019: quarterly results
Jul 2019
19 Jul · Board meeting
Meeting on 29 Jul 2019: quarterly results
May 2019
17 May · Board meeting
Meeting on 29 May 2019: audited results
Apr 2019
5 Apr · Board meeting
Meeting on 5 Apr 2019
Jan 2019
24 Jan · Board meeting
Meeting on 4 Feb 2019: quarterly results
Jul 2018
May 2017
3 May · Board meeting
Feb 2017
23 Feb · Board meeting